ERNA Return on Tangible Equity | Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc. (ERNA) Return on Tangible Equity

2026-06-30: Return Tang Equity -1060.29%.
2026-03-31: Return Tang Equity -236.49%.
2025-12-31: Return Tang Equity -3944.82%.
2025-09-30: Return Tang Equity -1201.83%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-1060.29%
2026-03-31	-236.49%
2025-12-31	-3944.82%
2025-09-30	-1201.83%
2025-06-30	-1821.00%
2025-03-31	576.61%
2024-12-31	12985.13%
2024-09-30	94.72%
2024-06-30	226.30%
2024-03-31	419.70%
2023-12-31	-11464.55%
2023-09-30	-1317.79%
2023-06-30	-1192.59%
2023-03-31	-386.41%
2022-12-31	-244.24%
2022-09-30	-414.26%
2022-06-30	-838.00%
2022-03-31	-1222.36%
2021-12-31	-701.50%
2021-09-30	-601.30%
2021-06-30	-116.52%
2021-03-31	-864.21%
2020-12-31	2131.00%
2020-09-30	-76.05%
2020-06-30	-45.30%
2020-03-31	-35.91%
2019-12-31	-24.51%
2019-09-30	-14.07%
2019-06-30	-2.43%
2019-03-31	-3.05%
2018-12-31	-4.64%
2018-09-30	-19.32%
2018-06-30	-29.63%
2018-03-31	-43.43%
2017-12-31	-30.53%
2017-09-30	-17.79%
2017-06-30	-25.40%
2017-03-31	-40.53%
2016-12-31	-94.23%
2016-09-30	-435.56%
2016-06-30	-336.44%
2016-03-31	-301.10%
2015-12-31	-252.66%
2015-09-30	-212.22%
2015-06-30	-157.76%
2015-03-31	-88.65%
2014-12-31	-51.80%
2014-09-30	-32.34%
2014-06-30	-20.68%
2014-03-31	-18.25%
2013-12-31	-13.39%
2013-09-30	-1.27%
2013-06-30	3.70%
2013-03-31	-5.50%
2012-12-31	-16.45%
2012-09-30	-49.11%
2012-06-30	-68.06%
2012-03-31	-68.26%
2011-12-31	-80.09%
2011-09-30	-38.58%
2011-06-30	-18.27%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-3945.10%
2024-12-31	12985.13%
2023-12-31	-11464.55%
2022-12-31	-244.25%
2021-12-31	-701.50%
2020-12-31	2131.00%
2019-12-31	-24.51%
2018-12-31	-4.64%
2017-12-31	-30.53%
2016-12-31	-94.23%
2015-12-31	-252.66%
2014-12-31	-51.80%
2013-12-31	-13.39%
2012-12-31	-16.45%
2011-12-31	-80.09%
2010-12-31	-5.57%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Pulmatrix, Inc. (PULM)	United States	$0.006B
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B